Oppenheimer downgrades Morgan Stanley post Q2: Sell or Hold?
Analysts at Oppenheimer downgraded Morgan Stanley (NYSE: MS) to “Market Perform” from “Outperform” today, following its Q2 earnings release yesterday. This downgrade comes despite the stock trading above Oppenheimer’s target price of $102, fueled by a robust Q2 performance that surpassed Wall Street expectations. Q2 earnings In Q2 2024, Morgan Stanley reported a robust set